Found: 6
Select item for more details and to access through your institution.
The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 5, p. 537, doi. 10.1007/s40258-014-0110-0
- By:
- Publication type:
- Article
Decision-making on listing new medicines for public funding in New Zealand: the case of ‘new’ type 2 diabetes medications.
- Published in:
- Journal of Primary Health Care, 2022, v. 14, n. 1, p. 13, doi. 10.1071/HC21122
- By:
- Publication type:
- Article
The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 11, p. 1063, doi. 10.1007/s40273-013-0095-9
- By:
- Publication type:
- Article
The impact on health outcome measures of switching to generic medicines consequent to reference pricing: the case of olanzapine in New Zealand.
- Published in:
- Journal of Primary Health Care, 2015, v. 7, n. 2, p. 94, doi. 10.1071/hc15094
- By:
- Publication type:
- Article
How well does social work education in Aotearoa New Zealand prepare social workers to work with people claiming welfare benefits and what could be done better?
- Published in:
- Aotearoa New Zealand Social Work Review, 2024, v. 36, n. 1, p. 60
- By:
- Publication type:
- Article
Evaluating general practitioners' opinions on issues concerning access to medicines in New Zealand.
- Published in:
- Journal of Pharmaceutical Health Services Research, 2015, v. 6, n. 3, p. 145, doi. 10.1111/jphs.12100
- By:
- Publication type:
- Article